COM:SIRONABIOCHEM
Sirona Biochem Corp.
- Stock
Last Close
0.02
25/04 20:00
Market Cap
9.64M
Beta: -
Volume Today
15K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Oct '14 | Oct '15 | Oct '16 | Oct '17 | Oct '18 | Oct '19 | Oct '20 | Oct '21 | Oct '22 | Oct '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 51.18K - | 66.60K 30.13% | 15.42K 76.85% | -0.00 - | |||||||
average payables | 334.07K - | 194.11K 41.90% | 94.63K 51.25% | 250.08K 164.28% | 301.41K 20.53% | 302.76K 0.45% | 467.05K 54.27% | 458.97K 1.73% | 306.50K 33.22% | 716.40K 133.73% | |
average receivables | 528.11K - | 533.79K 1.08% | 449.22K 15.84% | 671.94K 49.58% | 620.47K 7.66% | 380.19K 38.73% | 476.38K 25.30% | 469.24K 1.50% | 619.74K 32.07% | 620.71K 0.16% | |
book value per share | 0.02 - | 0.02 11.67% | 0.01 42.25% | -0.01 230.63% | -0.01 2.80% | 0.01 182.66% | 0.00 98.07% | -0.00 301.85% | 0.00 310.27% | -0.01 1,219.35% | |
capex per share | -0.00 - | -0.00 18.52% | -0.00 63.92% | -0.00 29.18% | -0.00 - | ||||||
capex to depreciation | -8.86 - | -1.54 82.65% | -0.92 40.39% | -0.95 3.20% | -4.84 - | ||||||
capex to operating cash flow | 0.13 - | 0.13 0.19% | 0.06 48.91% | 0.07 8.66% | 0.02 - | ||||||
capex to revenue | -1.13 - | -40.91 3,517.15% | -0.38 99.08% | -32.12 8,411.38% | -0.44 - | ||||||
cash per share | 0.01 - | 0.01 114.18% | 0.00 65.53% | 0.00 55.44% | 0.00 15.47% | 0.02 838.30% | 0.01 63.39% | 0.00 50.05% | 0.00 48.48% | 0.00 29.63% | |
days of inventory on hand | -0.00 - | ||||||||||
days payables outstanding | 42.00K - | ||||||||||
days sales outstanding | 1.01K - | 22.46K 2,120.30% | 411.60 98.17% | 62.57K 15,101.74% | 86.66 99.86% | 1.23K 1,317.41% | 1.71K 39.42% | 602.61 64.81% | 432.93 28.16% | 4.66K 977.38% | |
debt to assets | 0.20 - | 0.29 49.81% | 0.31 5.30% | 2.15 593.11% | 3.26 51.63% | 0.36 88.83% | 0.58 59.72% | 0.66 13.70% | 0.36 44.85% | 2.12 480.57% | |
debt to equity | 0.38 - | 0.59 58.15% | 0.62 4.15% | -1.32 312.55% | -1.11 15.71% | 0.71 163.71% | 26.20 3,604.50% | -8.77 133.46% | 2.19 125.00% | -0.87 139.65% | |
dividend yield | |||||||||||
earnings yield | -0.27 - | -0.13 50.22% | -0.11 20.75% | -0.20 87.91% | -0.08 61.88% | -0.05 32.23% | -0.07 44.61% | -0.05 30.42% | -0.12 133.69% | -0.14 13.00% | |
enterprise value | 13.24M - | 26.49M 100.02% | 28.55M 7.78% | 24.91M 12.74% | 19.02M 23.66% | 86.65M 355.57% | 55.52M 35.92% | 44.83M 19.26% | 29.59M 33.99% | 20.30M 31.40% | |
enterprise value over ebitda | -3.84 - | -8.07 110.08% | -10.25 27.09% | -10.81 5.47% | -20.85 92.86% | -19.50 6.50% | -13.48 30.88% | -19.67 45.94% | -8.40 57.29% | -7.12 15.31% | |
ev to operating cash flow | -7.12 - | -10.25 43.96% | -13.58 32.41% | -9.97 26.55% | -29.09 191.77% | -24.34 16.32% | -26.29 7.99% | -20.77 20.98% | -13.59 34.57% | -11.55 15.01% | |
ev to sales | 63.76 - | 3.31K 5,097.22% | 79.20 97.61% | 4.56K 5,652.95% | 14.87 99.67% | 638.31 4,191.44% | 525.21 17.72% | 167.25 68.15% | 44.04 73.67% | 583.66 1,225.30% | |
free cash flow per share | -0.02 - | -0.02 18.32% | -0.01 33.27% | -0.02 19.51% | -0.00 77.32% | -0.02 364.73% | -0.01 46.00% | -0.01 1.43% | -0.01 4.06% | -0.01 22.83% | |
free cash flow yield | -0.16 - | -0.11 31.22% | -0.08 27.33% | -0.12 49.68% | -0.04 67.35% | -0.04 3.26% | -0.04 3.46% | -0.05 24.66% | -0.07 52.85% | -0.09 27.60% | |
graham net net | -0.01 - | -0.00 30.17% | -0.00 5.79% | -0.01 288.37% | -0.01 0.62% | 0.01 169.65% | -0.00 108.06% | -0.00 48.78% | -0.00 80.28% | -0.01 4,330.35% | |
graham number | 0.10 - | 0.10 2.21% | 0.06 35.17% | 0.09 40.00% | 0.05 47.82% | 0.07 58.79% | 0.01 87.51% | 0.01 5.38% | 0.02 75.63% | 0.05 176.59% | |
income quality | 0.53 - | 0.73 38.14% | 0.71 2.97% | 0.56 20.76% | 0.51 8.34% | 0.78 52.36% | 0.51 34.69% | 0.94 83.15% | 0.61 34.60% | 0.69 12.91% | |
intangibles to total assets | 0.62 - | 0.48 22.59% | 0.55 13.46% | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -43.48 - | -40.26 7.39% | -73.12 81.60% | -17.10 76.61% | -4.02 76.49% | -38.06 846.49% | -314.52 726.27% | -686.85 118.38% | -130.80 80.96% | -14.20 89.15% | |
interest debt per share | 0.01 - | 0.01 67.64% | 0.01 41.03% | 0.02 181.04% | 0.02 10.38% | 0.01 48.06% | 0.01 32.91% | 0.00 32.91% | 0.00 44.63% | 0.01 358.54% | |
inventory turnover | -83.40T - | ||||||||||
invested capital | 0.38 - | 0.59 58.15% | 0.62 4.15% | -1.32 312.55% | -1.11 15.71% | 0.71 163.71% | 26.20 3,604.50% | -8.77 133.46% | 2.19 125.00% | -0.87 139.65% | |
market cap | 13.18M - | 26.64M 102.04% | 28.20M 5.85% | 22.50M 20.21% | 16.85M 25.12% | 88.83M 427.24% | 55.81M 37.17% | 44.76M 19.81% | 29.54M 33.99% | 18.69M 36.74% | |
net current asset value | -384.94K - | 23.20K 106.03% | -429.90K 1,953.11% | -2.04M 374.66% | -2.26M 10.80% | 2.19M 196.84% | 10.12K 99.54% | -124.83K 1,333.51% | 195.79K 256.84% | -2.52M 1,387.29% | |
net debt to ebitda | -0.02 - | 0.04 355.03% | -0.13 387.04% | -1.05 721.25% | -2.38 127.07% | 0.49 120.67% | 0.07 85.49% | -0.03 144.61% | -0.01 56.56% | -0.56 3,984.25% | |
net income per share | -0.03 - | -0.03 14.37% | -0.02 27.22% | -0.03 50.04% | -0.01 73.52% | -0.02 205.01% | -0.02 19.11% | -0.01 44.98% | -0.01 46.70% | -0.01 31.65% | |
operating cash flow per share | -0.02 - | -0.02 18.29% | -0.01 29.39% | -0.02 18.89% | -0.00 75.73% | -0.02 364.73% | -0.01 47.17% | -0.01 0.76% | -0.01 4.06% | -0.01 22.83% | |
payables turnover | 0.01 - | ||||||||||
receivables turnover | 0.36 - | 0.02 95.50% | 0.89 5,356.19% | 0.01 99.34% | 4.21 72,104.73% | 0.30 92.94% | 0.21 28.28% | 0.61 184.18% | 0.84 39.19% | 0.08 90.72% | |
research and ddevelopement to revenue | 2.89 - | 162.41 5,525.81% | 3.62 97.77% | 182.64 4,947.29% | 0.74 99.59% | 9.31 1,157.83% | 12.38 32.93% | 4.31 65.23% | 1.61 62.68% | 47.64 2,864.91% | |
return on tangible assets | -2.74 - | -1.45 47.22% | -2.11 45.78% | -3.57 69.00% | -1.65 53.65% | -1.07 35.32% | -1.93 80.97% | -1.79 7.38% | -2.76 53.87% | -2.46 10.60% | |
revenue per share | 0.00 - | 0.00 96.72% | 0.00 3,811.77% | 0.00 98.48% | 0.01 21,595.69% | 0.00 90.94% | 0.00 30.67% | 0.00 150.02% | 0.00 138.40% | 0.00 95.05% | |
roe | -1.97 - | -1.51 23.31% | -1.90 26.01% | 2.19 214.86% | 0.56 74.24% | -2.08 468.98% | -87.22 4,097.50% | 23.77 127.26% | -16.59 169.77% | 1.01 106.11% | |
roic | -1.40 - | -0.93 33.64% | -1.07 15.45% | -2.89 169.23% | -2.37 17.98% | -1.14 51.63% | -2.91 154.23% | -2.74 6.01% | -4.87 78.08% | 7.52 254.43% | |
sales general and administrative to revenue | 14.84 - | 276.00 1,759.57% | 5.52 98.00% | 273.70 4,858.43% | 0.80 99.71% | 21.07 2,544.24% | 24.60 16.78% | 4.01 83.69% | 3.98 0.86% | 26.75 572.51% | |
shareholders equity per share | 0.02 - | 0.02 11.67% | 0.01 42.25% | -0.01 230.63% | -0.01 2.80% | 0.01 182.66% | 0.00 98.07% | -0.00 301.85% | 0.00 310.27% | -0.01 1,219.35% | |
stock based compensation to revenue | 3.49 - | 68.94 1,873.07% | 0.77 98.89% | 20.62 2,586.21% | 0.10 99.53% | 7.79 8,008.08% | 15.35 97.19% | 1.24 91.95% | 2.18 76.33% | 0.88 59.78% | |
tangible asset value | -351.81K - | 52.38K 114.89% | -151.82K 389.87% | -2.04M 1,244.04% | -2.26M 10.80% | 2.19M 196.84% | 47.40K 97.84% | -97.02K 304.69% | 214.51K 321.12% | -2.51M 1,270.72% | |
tangible book value per share | -0.00 - | 0.00 112.68% | -0.00 351.47% | -0.01 1,244.90% | -0.01 2.80% | 0.01 182.66% | 0.00 98.07% | -0.00 301.85% | 0.00 310.27% | -0.01 1,219.35% | |
working capital | 729.55K - | 1.22M 66.96% | 589.37K 51.61% | -2.09K 100.36% | -1.09M 51,752.05% | 3.34M 407.32% | 1.07M 67.93% | 518.50K 51.55% | 407.45K 21.42% | -843.55K 307.03% |
All numbers in USD (except ratios and percentages)